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 2 
Abstract  1 
Hox genes encode transcription factors that regulate morphogenesis in all animals 2 
with bilateral symmetry. Although Hox genes have been extensively studied, their 3 
molecular function is not clear in vertebrates, and only a limited number of genes 4 
regulated by Hox transcription factors have been identified. Hoxa2 is required for 5 
correct development of the second branchial arch, its major domain of expression. 6 
We now show that Meox1 is genetically downstream from Hoxa2 and is a direct 7 
target. Meox1 expression is downregulated in the second arch of Hoxa2 mouse 8 
mutant embryos. In chromatin immunoprecipitation (ChIP), Hoxa2 binds to Meox1 9 
proximal promoter. Two highly conserved binding sites contained in this sequence 10 
are required for Hoxa2-dependent activation of the Meox1 promoter. Remarkably, in 11 
the absence of Meox1 and its close homolog Meox2, the second branchial arch 12 
develops abnormally and two of the three the skeletal elements patterned by Hoxa2 13 
are malformed. Finally, we show that Meox1 can specifically bind the DNA 14 
sequences recognized by Hoxa2 on its functional target genes. These results provide 15 
new insight into the Hoxa2 regulatory network that controls branchial arch identity. 16 
 17 
Introduction 18 
In vertebrates, development of the face and neck starts with formation of the 19 
frontonasal mass and the branchial arches. The branchial arches are transient, 20 
repetitive structures in which cells of the cranial neural crest (CNC) and mesoderm 21 
are encapsulated by epithelia. Upon differentiation, each of the branchial arches 22 
contributes to head and neck specific skeletal elements, their associated muscles, 23 
blood supply and nerves. Morphogenesis of the branchial arches depends on a 24 
number of transcription factors and signaling molecules. Transcription factors of the 25 
Dlx and Hox families have a most prominent role, the first by regulating proximo-26 
distal patterning within each branchial arch (8), the latter by controlling branchial arch 27 
identity (3, 11, 17, 25).  28 
 3 
The second branchial arch (IIBA) contributes to the outer and middle ear and to part 1 
of the neck. Development of the IIBA is controlled by the transcription factor Hoxa2. 2 
In Hoxa2 mutant embryos, IIBA-skeletal derivatives are replaced by typical first 3 
branchial arch (IBA) skeletal elements in mirror image configuration (3, 11, 25). 4 
Hoxa2 belongs to the large family of Hox transcription factors, whose members 5 
specify the body axis of bilaterian organism, whether a segment of the embryo will 6 
form head, thorax or abdomen (7). The identification of Hox downstream effectors in 7 
vertebrates is complicated by the high redundancy of Hox genes, represented by 8 
multiple paralogs in vertebrate genomes. Although Hox genes have been the subject 9 
of extensive genetic analysis, few target genes have been identified (22, 29). The 10 
IIBA is one of the few embryonic districts in which inactivation of a single Hox gene 11 
has an unambiguous effect in mouse, and an effective model system to define Hox 12 
molecular function in vertebrate embryogenesis.  13 
How does Hoxa2 specify IIBA identity? Hoxa2 control of IIBA development appears 14 
to involve the repression of few transcription factors. At E10.0, before overt 15 
differentiation has begun in the IIBA, Hoxa2 negatively regulates transcription of Ptx1 16 
and Lhx6; their characterization has suggested that Hoxa2 patterns the IIBA by 17 
changing the competence of the CNC to respond to skeletogenic signals (5). At the 18 
same developmental stage, Hoxa2 directly represses Six2 expression, and this 19 
partially mediates Hoxa2 control over the IGF system (13, 14). Genetic experiments 20 
to dissect the role of the genes downstream of Hoxa2 have shown that correcting the 21 
expression levels of Six2 and Ptx1 ameliorates the Hoxa2 mutant phenotype (5, 13, 22 
14), indicating that repression of Six2 and Ptx1 is indeed required for IIBA-specific 23 
morphogenesis. However the limited extent of the rescue by inactivation of individual 24 
targets and its incomplete penetrance, suggest the existence of strong redundancies 25 
among these genes in the morphogenesis of the IIBA.  26 
A number of observations indicates that Hoxa2 controls IIBA identity by blocking a 27 
first arch default fate. Ptx1, Lhx6 and Six2, and the few additional genes identified as 28 
 4 
regulated by Hoxa2 (6, 28) are normally expressed in the IBA, but not in the IIBA, 1 
suggesting that Hoxa2 functions as a transcriptional repressor to prevent the 2 
expression of IBA- specific genes in the IIBA. Moreover, the IIBA gives rise to 3 
duplicates of IBA-skeletal elements in the absence of Hoxa2.  Is IIBA identity simply 4 
achieved by blocking a default IBA state or is there more to it? The finding that 5 
Hoxa2 is functionally relevant at E9.5 (Santagati et al., 2005), which is earlier than 6 
the stages at which expression of most identified Hoxa2 targets become apparent in 7 
Hoxa2 mutant IIBAs, indicates that the gene regulatory network (GRN) controlled by 8 
Hoxa2 in the IIBA must include additional target genes expressed at earlier 9 
developmental stages. Their identification is essential to clarify the structure and 10 
organization of the GRN that governs IIBA identity downstream of Hoxa2. 11 
Here we show that the earliest event controlled by Hoxa2 in the IIBA is the activation 12 
of the gene encoding the transcription factor Meox1. The Meox1 homeobox gene is 13 
strongly expressed in the somites during embryogenesis, and controls formation and 14 
differentiation of the somites and their derivatives (16). We find that, in the 15 
developing IIBA, Hoxa2 is associated to a highly conserved region of Meox1 16 
chromatin. We further show that the interaction of Hoxa2 with Meox1 promoter is 17 
sequence-specific and required for Meox1 activation. Our results show that Meox1 is 18 
genetically downstream of Hoxa2 and is a direct target. In addition, we find that 19 
Meox1 can specifically bind the DNA sequences recognized by Hoxa2 on its 20 
functional target genes, suggesting these transcription factors may share the control 21 
of downstream targets in the IIBA. Finally, the analysis of Meox1; Meox2 combined 22 
mutants reveals that IIBA derivatives develop abnormally in the absence of Meox 23 
genes. These findings link two co-expressed transcription factors in a novel 24 
molecular pathway in mouse embryonic development. In addition, they uncover a 25 
previously unidentified role for Meox genes in the morphogenesis of the branchial 26 
arches. 27 
 28 
 5 
Materials and methods 1 
Mutant and transgenic animals and embryos  2 
Hoxa2, Meox1, Meox2 null mice are described in Gendron-Maguire et al., 1993; 3 
Mankoo et al., 1999; Mankoo et al., 2003; Skuntz et al. 2009. Meox2+/tm1(lacZ)Mnko 4 
contains a ires-nls-lacZ knocked into Meox2 first exon. Animals experiments were 5 
carried out under ASPA 1986. 6 
Molecular and phenotypic analyses 7 
Whole mount and section in situ hybridization was performed as described (Kanzler 8 
et al., 1998), using Hoxa2 (Mallo, 1997), Crabp1 (a gift from Rudolph Grosschedl) 9 
and Meox1 probe, amplified from IIBA cDNA using primers Meox1F 5’-10 
CACAGGAGCAGGACCGAGAGG -3’; Meox1R 5’- 11 
CCGGAACACGCAGGATAGGTCC-3’. Skeletal phenotypes were analyzed by alcian 12 
blue/alizarin red staining (Mallo and Brändlin, 1997). 13 
RT-PCR 14 
RT-PCR was performed as described (Kutejova et al., 2005), using RNA extracted 15 
from 106 cells dissociated from IBA and IIBA of E10.5 embryos, using 1% trypsin, 16 
0.1% EDTA, filtered through a cell strainer (BD), and cultured in DMEM 10%FCS for 17 
3 days. cDNA was subjected to 24 cycles of amplification using the following primers: 18 
Lhx6F 5’-GGAGATCTACTGCAAGATGGACTAC-3; Lhx6R 5’-19 
CCGTCATGTCCGCTAGCTTCTG-3; Pitx1F 5’-AATCGTCCGACGCTGATCTGCC-3; 20 
Pitx1R 5’-CCTTGCACAGGTCCAACTGCTG-3’; Six2 and Hoxa2 primers are 21 
described in Kutejova et al. 2008. 22 
Chromatin immunoprecipitation (ChIP) and electrophoretic mobility shift assay 23 
(EMSA) 24 
ChIP was performed according to Kutejova et al. 2008. Meox1 mouse cDNA was 25 
amplified from E10.0 IIBA cDNA and cloned into pcDNA3 (Invitrogen). pcDNA3-26 
Meox1-HA contains a HA tag before the stop codon; pcDNA3-Hoxa2 construct has 27 
been described (Kutejova et al., 2005). EMSA was performed as described (Kutejova 28 
 6 
et al., 2005). Meox1 promoter and its mutant versions were labeled using !32P-dATP. 1 
For the supershift experiment, 40 ng of anti-HA antibodies (rat monoclonal 3F10, 2 
Roche) were added to the reaction. 3 
Cell transfection 4 
IBA mandibular components were isolated from 10 mouse embryos collected at 5 
E10.5. Cells were dissociated and resuspended in DMEM 10%FCS. 500 ng total 6 
DNA (250ng Meox1-lacZ or mutMeox1-lacZ construct and 250 ng pCDNA3-Hoxa2 or 7 
pCDNA3) and 3 ul Fugene (Roche) were added to identical aliquots of the 8 
resuspended cells. Each aliquot was plated onto a well of a 24-well plate. After 24 hr 9 
incubation at 37ºC, cells were fixed and stained for "-galactosidase activity. 10 
 11 
Results 12 
Hoxa2 regulates Meox1 expression in the IIBA 13 
To identify early targets of Hoxa2, we compared the expression profiles of wild-type 14 
and Hoxa2 mutant IIBAs at E9.5 in mouse, when migration of the Hoxa2-positive 15 
CNC into the IIBA has just been completed (15, 24). The gene encoding the 16 
transcription factor Meox1 was among the few genes differentially expressed, and its 17 
signal was decreased two-fold in the absence of Hoxa2. 18 
Meox1 signal was not detected in the Hoxa2-positive CNC prior or during migration 19 
to the IIBA (not shown). Meox1 signal was first evident in the branchial area at E9.0, 20 
and predominantly in the IIBA (Fig. 1A). At E9.5 strong expression of Meox1 was 21 
detected in the proximal area of the IIBA, and expression was excluded from the 22 
distal domain of the arch; strong expression was also found in the third arch (IIIBA) 23 
(Fig. 1B). Around E10.0 only a small area of the IIBA and the IIIBA remained positive 24 
for Meox1 (Fig. 1C) and after E10.5 no Meox1 signal could be detected in the IIBA 25 
(not shown). At all the stages examined, Meox1 expression was excluded from the 26 
IBA. 27 
 7 
To confirm that Hoxa2 regulates Meox1 expression, we performed ISH on E9.5 1 
Hoxa2 mutant embryos. Meox1 expression was specifically lost in the IIBA of Hoxa2 2 
mutant embryos (Fig. 1E). 3 
At E9.5, when migration of Hoxa2-positive cells is completed, Hoxa2 was expressed 4 
in most of the IIBA (Fig. 1F), while Meox1 was transcribed only in the proximal area 5 
of the IIBA (Fig. 1D). Meox1 is expressed in a subpopulation of the Hoxa2-positive, 6 
Crabp1-positive cranial neural crest of the IIBA (Fig. 1G-I).  7 
These results indicate that Hoxa2 positively controls Meox1 expression in the IIBA. 8 
They also show that the temporal and spatial expression of Meox1 is more restricted 9 
as compared to the one of Hoxa2. Therefore Hoxa2 appears to be necessary, but not 10 
sufficient to activate Meox1 expression.  11 
 12 
Hoxa2 binds a conserved sequence within Meox1 proximal promoter 13 
Hoxa2 contains a DNA binding domain, which interacts in a sequence-specific 14 
fashion with the chromatin of target genes to control their transcription. Association of 15 
Hoxa2 to Meox1 chromatin in vivo is therefore an essential requisite for Meox1 direct 16 
regulation by Hoxa2. Loss of Hoxa2 function generates an identical IIBA phenotype 17 
in mouse, frog and fish (2, 3, 11, 12, 25), suggesting that Hoxa2 responsive elements 18 
should be conserved across vertebrates.  The CORG database (9) identified Meox1 19 
proximal promoter (corresponding to positions -236 to -33 in mouse) as perfectly 20 
conserved from human to fish (Fig. 2A). IIBA-extracted, Hoxa2-immunoprecipitated 21 
chromatin showed a substantial enrichment for the most proximal Meox1 promoter 22 
region, while no enrichment was detected for an unrelated, control promoter (Fig. 23 
2B). These results demonstrate that at E10.0, when Hoxa2 is strongly expressed 24 
(Fig. 2C) and still required for activation of Meox1 transcription in the IIBA, Hoxa2 is 25 
bound to Meox1 chromatin in vivo.  26 
Binding of Hoxa2 to its in vivo target Six2 is mediated by two conserved TAAT 27 
consensus sites (13). The Meox1 promoter region enriched in ChIP assays contains 28 
 8 
an ATTA motif, embedded in a perfectly conserved stretch of flanking nucleotides, 1 
and a second one located on the opposite strand (Fig. 2A). Incubation of the 2 
conserved Meox1 proximal promoter with in vitro translated Hoxa2 in electrophoretic 3 
mobility shift assay (EMSA) resulted in the formation of a retarded complex, which 4 
was supershifted by the addition of the anti-Hoxa2 antibody (Fig. 2D). In contrast, 5 
incubation of the probe in the presence of unprogrammed reticulocytes did not result 6 
in any retarded complex, nor did addition of the antibody have any effect (Fig. 2D). 7 
Mutating both TAAT consensus completely abolished binding of Hoxa2 to the probe 8 
(Fig. 2D), while nucleotide substitutions introduced in each of the single TAAT sites 9 
partially reduced Hoxa2 binding (Fig. 2D). Finally, Hoxa2 binding to the probe was 10 
competed by increasing molar concentration of wild-type oligonucleotides 11 
reproducing the TAAT motif and flanking nucleotides, but not mutant oligonucleotides 12 
(Fig. 2E). The oligonucleotide reproducing binding site 1 (BS1) was more efficient in 13 
competing Hoxa2 binding to the probe, indicating a higher affinity of Hoxa2 for 14 
binding site 1 (Fig. 2E). 15 
We used IBA-derived cells to investigate if binding of Hoxa2 to Meox1 promoter may 16 
control gene transcription. Experimental evidence indicates that IBA and IIBA cells 17 
share a similar ground state, which is modified in the IIBA by the presence of Hoxa2 18 
(3, 11, 21, 25); IBA cells appear therefore capable to provide an environment 19 
equivalent to IIBA cells (without Hoxa2). When isolated from E10.0 branchial arches 20 
and grown in monolayers, these cells maintain the molecular identity of the area of 21 
origin, as estimated by expression of Hoxa2 and few of its target genes in IBA- and 22 
IIBA-derived cells after three days in culture (Fig 3A, B). 23 
Cells dissociated from E10.0 IBAs were transfected with a 4.6kbMeox1-lacZ 24 
construct, containing the Meox1 promoter (-4642 to + 22) fused to a lacZ reporter 25 
gene. Meox1 promoter activity, assessed by counting the number of cells that turned 26 
blue after transfection, was very low in these cells (less than 20 blue cells were 27 
counted in each individual experiment). A significant increase in the number of cells 28 
 9 
expressing lacZ (> 200, i.e. 10 fold increase) was observed when Hoxa2 was co-1 
transfected together with 4.6kbMeox1-lacZ (Fig. 3C). Introducing the nucleotide 2 
substitutions shown to abolish Hoxa2 binding (4.6kbmutMeox1-lacZ) (Fig. 2D) did not 3 
affect the basal activity of the promoter. However, unlike its wild-type version, 4 
addition of Hoxa2 failed to activate the reporter gene (Fig. 3C). The lack of effect 5 
described above shows that expression of Hoxa2 in these cells did not affect cell 6 
number; this observation was also confirmed by using an unrelated promoter (not 7 
shown). 8 
In conclusion, these results show that Hoxa2 interacts with the proximal region of the 9 
Meox1 promoter in vivo and that this interaction, which is sequence-specific and 10 
mediated by two TAAT, is required for Meox1 activation. 11 
 12 
Meox homeodomain transcription factors control formation of the IIBA-specific 13 
cartilages 14 
We analyzed Meox1 mutant mice to understand whether Meox1 activation 15 
contributes to IIBA morphogenesis. Skeletal analysis of Meox1 mutant mice showed 16 
no evident phenotype in CNC derivatives of the IIBA, but when the Meox1 mutation 17 
was combined with mutation in the homolog Meox2 (also not showing a IIBA 18 
phenotype), two of the three elements that are controlled by Hoxa2 were abnormal. 19 
As sporadically observed in Hoxa2 heterozygous (20), the styloid process was split in 20 
two fragments (Fig. 4B). Its distal part failed to extend distally and formed close to 21 
IBA cartilages, resembling an intermediate situation towards the Hoxa2 mutant 22 
phenotype, in which the IIBA cartilages are formed much closer to their IBA mirror-23 
image counterparts with respect to the wild-type (Figs. 4A-C). The lesser horn of the 24 
hyoid bone also developed abnormally (not shown). In addition, similar to the Hoxa2 25 
mutants, whose basioccipital bone has an abnormal shape, Meox1 single mutants 26 
showed defects in this structure. These abnormalities were enhanced in Meox1-/-; 27 
Meox2-/- mutants, resulting in a hypoplastic basioccipital bone (Fig. 4E).  28 
 10 
The above data indicate that Meox1 functions redundantly with its homolog Meox2 1 
during the development of the IIBA, consistent with the experimental evidence that 2 
Meox1 and Meox2 act redundantly to control somite development (Mankoo et al., 3 
2003). Meox2 expression in the IIBA is not equivalent to Meox1 and appears later in 4 
the development of the IIBA; although we could detect Meox2 transcripts in the 5 
developing somites by ISH, we were unable to detect Meox2 expression in the 6 
branchial arches at stages earlier than E12.5. However LacZ staining of 7 
Meox2+/tm1(lacZ)Mnko embryos indicated that the Meox2 allele is expressed in the 8 
posterior-distal domain of the IIBA already at E10.75 (Fig. 5).  9 
 10 
Meox1 binds Hoxa2 target sequences 11 
The identification of the genes regulated by Meox1 in the IIBA is complicated by the 12 
apparent redundant function of Meox1 and Meox2. Meox1 regulates Bapx1 13 
expression in developing somites (26) and Bapx1 is under Hoxa2 regulation in the 14 
IIBA (28), suggesting that Meox1 may mediate Hoxa2 regulation of Bapx1 in the 15 
IIBA. 16 
Meox1 binding site on its functional target Bapx1 (Rodrigo et al., 2004) is very similar 17 
to the binding sites recognized by Hoxa2 on its direct targets, Six2 (13) and Meox1 18 
itself. High-resolution analysis of sequence preferences attributes identical DNA-19 
binding specificities to Meox1 and Hoxa2 (4). We ran a blast search (1) using Meox1 20 
homeodomain and identified Hoxa2 homeodomain as a hit, with 68% residues 21 
identity and up to 75% positives residues. These observations predict that Meox1 22 
and Hoxa2 may bind the same sequences in vitro. Hoxa2 directly regulates 23 
transcription of Six2 gene by binding two closely spaced sites on Six2 proximal 24 
promoter (13). In band-shift assays, Six2 proximal promoter interacted similarly with 25 
Meox1 and Hoxa2-programmed reticulocytes (Fig. 6A). Double stranded 26 
oligonucleotides, reproducing the Hoxa2 binding sites identified in the Six2 gene, 27 
specifically competed Meox1 and Hoxa2 binding to Six2 promoter, and both Hoxa2 28 
 11 
and Meox1 showed a higher affinity for binding site 1 (BS1). Conversely, double 1 
stranded oligonucleotides containing mutations in the TAAT core did not disturb 2 
complexes formation (Fig. 6A). Meox1, like Hoxa2, binds Meox1 promoter: incubation 3 
of a probe containing Meox1 proximal promoter gave rise to a strong complex in the 4 
presence of Meox1-HA programmed-reticulocytes. The specificity of the complex 5 
was confirmed by the addition of an anti-HA antibody (Fig. 6B).  6 
The finding that Meox1 and Hoxa2 bind the same sequences in vitro suggests that 7 
these transcription factors could, at least in part, share the control of downstream 8 
targets in the IIBA. 9 
 10 
Discussion 11 
Activation of Meox1 by Hoxa2 12 
Hoxa2 controls IIBA identity. Diverse experimental evidence indicates that Hoxa2 13 
controls the production of IIBA structures by blocking a first arch default fate. First, 14 
morphogenesis in the IIBA follows patterns typical of the proximal region of the IBA in 15 
the absence of Hoxa2 (3, 11, 25). Second, Hoxa2 appears to act as a repressor and 16 
mainly negatively regulates the expression of IBA-specific developmental regulators 17 
in the IIBA (5, 6, 13, 28).  18 
Here we identified a new downstream target of Hoxa2, the transcription factor 19 
Meox1. The addition of Meox1 to Hoxa2 GRN uncovers a novel aspect of Hoxa2 20 
activity in the IIBA, which does not directly function to prevent the execution of the 21 
molecular program that imposes a first arch fate. Unlike all the previously identified 22 
Hoxa2 target genes, Meox1 expression is never detected in the IBA. Activation of 23 
Meox1 by Hoxa2 is mediated by direct interaction of Hoxa2 with a phylogenetically 24 
conserved region in the Meox1 promoter. Meox1 expression is detected as early as 25 
E9.0, when Hoxa2-positive cells settle in the IIBA. Meox1 is transiently expressed 26 
and by the time the other known Hoxa2 targets appear in the Hoxa2 mutant IIBA (i.e. 27 
around E10.5), its expression has ceased.  28 
 12 
Few similarities can be found between the regulation of Meox1 and another bona fide 1 
Hoxa2-regulated promoter in the IIBA, Six2 (13, 14). Hoxa2 binding sites are closely 2 
spaced and located in the proximity of the transcription start site in both Six2 and 3 
Meox1 promoters. Also in both cases the activity of Hoxa2 appears to require 4 
additional factors, namely Pax and Eya to regulate Six2 (31). Spatial and temporal 5 
expression of Meox1 in the IIBA is more restricted than the expression of Hoxa2 (15, 6 
24), indicating that Hoxa2 is necessary, but it is not sufficient to activate Meox1 7 
expression. However, Hoxa2 activates Meox1 and represses Six2 transcription; 8 
Hoxa2 repressor activity has been mapped to the protein region N-terminal to the 9 
homeodomain (27, 31). The molecular basis of this regulatory switch, also common 10 
to other Hox proteins (23, 27), is unknown. The molecular composition of the IIBAs at 11 
different developmental stages (the temporal dynamics of Meox1 activation and Six2 12 
repression are clearly different, almost complementary) or the presence of additional 13 
cis-regulatory modules in Six2 and Meox1 promoters, able to recruit specific co-14 
activators or co-repressors, may affect Hoxa2 function.  15 
The Hoxa2 GRN: a highly redundant network? 16 
Hoxa2 controls morphogenesis of the IIBA, and defines the shape and position of 17 
IIBA cartilages. Hoxa2 regulates Meox1 expression and Meox1 and Meox2 control 18 
morphogenesis of IIBA skeletal elements. Taken together, it is highly likely that 19 
Meox1 partially mediates Hoxa2 function in the IIBA. The finding that Meox1 null 20 
mutants do not display a IIBA phenotype, but Meox1; Meox2 null mutants have 21 
defects in the skeletal elements that are controlled by Hoxa2, suggests that Meox1 22 
function in the IIBA can be compensated by Meox2. This is similar to what observed 23 
in the developing somites, where Meox2 and Meox1 act redundantly (16). However, 24 
differently from the somites, Meox1 and Meox2 spatio-temporal expressions in the 25 
IIBA are almost complementary. Meox2 is expressed in distal areas of the IIBA, 26 
opposite to the antero-proximal expression of Meox1. Expression profiling of wild-27 
type and mutant IIBAs, collected from E10.0 to E11.5, indicates that in the absence 28 
 13 
of Hoxa2 Meox1 transcript levels are downregulated at all stages examined, while 1 
changes in Meox2 expression are only detected at the latest stage examined 2 
(E11.5), suggesting they are likely to be indirect effects of Hoxa2 absence (N. 3 
Bobola, unpublished results). The combined Meox1; Meox2 null phenotype in the 4 
IIBA indicates that Meox1 and Meox2 can compensate for each other’s loss. Their 5 
differences in expression, however, raise questions about the effective capacity of 6 
Meox2 to compensate the loss of Meox1 in the cells where Meox1 is normally 7 
expressed. Could other factors, in addition to Meox2, compensate for Meox1 8 
absence? 9 
One of the most intriguing findings resulting from the analysis of Hoxa2 activity during 10 
branchial arch development is that, while Hoxa2 loss of function generates strong 11 
phenotypes, the network downstream of Hoxa2 appears highly resistant to 12 
perturbations. Correcting Six2, Ptx1 and Gbx2 upregulation in Hoxa2 mutant 13 
embryos has mild or no effect on the development of the IIBA (5, 14) (M. Carapuco 14 
and M. Mallo, unpublished results). Similarly we show here that Meox1-null mice do 15 
not have a phenotype, while Meox1; Meox2 null mutants have IIBA defects. The 16 
simplest interpretation is that we observe mild defects because the genes analyzed 17 
do not include the crucial Hoxa2 functional targets, which still need to be identified.  18 
An alternative possibility, which takes into account that two of the four genes 19 
analyzed (Meox1 and Six2) are bona fide direct targets of Hoxa2, is that the GRN 20 
downstream of Hoxa2 is highly robust and is able to cope with modifications in the 21 
activity of its members. Indeed, the variability observed in the rescue of the 22 
phenotype in Hoxa2; Six2-null mutants (5, 14), indicates a high degree of 23 
redundancy, with other genes able to compensate Six2 function. Although we 24 
currently lack systematic evidence to substantiate this hypothesis, it is interesting to 25 
speculate further. Hoxa2 GRN robustness may derive from recruiting genes with 26 
considerable redundant roles, e.g. genes that belong to families, and whose 27 
members are also present in the IIBA (Meox1 and Meox2; Six2, Six1 and Six4).  28 
 14 
It is often found that changing the level of a transcription factor alters the expression 1 
level of a small subset of its predicted target genes; one of the possible explanations 2 
for this finding, other than a lack of function, is that related family members might 3 
bind to the same sites and have the same function (10). The structure of the Hoxa2 4 
transcriptional network, where most of the Hoxa2 downstream targets identified so 5 
far encode for homeodomain transcription factors (5, 13, 14), may also contribute to 6 
the functional stability of the network. Homeodomain proteins regulate transcription of 7 
their target genes by binding to specific nucleotide sequences. A survey of the 8 
binding preferences of Hoxa2 targets, according to the interactive prediction tool 9 
developed in Noyes et al. (19) and to high-throughput binding site selection (4), 10 
shows that Meox1, Lhx6 (5), Ptx1 (5), Msx1 (28), Gbx2 (6) and Hoxa2 itself interact 11 
with very similar, if not identical nucleotides sequences (Fig. 7). We showed in this 12 
paper that Meox1 specifically interacts with the sequences recognized by Hoxa2, and 13 
its binding abilities are comparable to the ones of Hoxa2.  14 
Recent genome- wide profiling of site-specific transcription factors has discovered 15 
that transcription factors bind thousands of binding sites in the genome (10), pointing 16 
at functional redundancy as a built-in safeguard for maintaining accurate regulation of 17 
the genome. The observed enrichment in transcription factors with similar binding 18 
affinities could provide a quantitative backup to the Hoxa2 GRN function. For 19 
instance, elimination of one GRN member could allow a higher level of binding of 20 
another GRN member. Homeodomain proteins recognize short sequences that are 21 
widespread throughout the genome, and it is believed that only a small percentage of 22 
all occurrences of a motif are actually bound by these proteins (18). A global map of 23 
the binding sites of Hoxa2 GRN members in vivo could discover potential overlaps on 24 
target promoters. These data would provide a molecular basis for the network 25 
redundancy and explain the recurring finding that loss of function of Hoxa2 targets 26 
has only a very partial, if no effect on the phenotype. 27 
The developing somites represent the main domain of Meox1 expression, and the 28 
 15 
area of the embryo most affected in the absence of Meox1 (16). Hox genes are 1 
expressed in somites and control morphogenesis of the axial skeleton (30). These 2 
observations raise the intriguing possibility that Meox1 might be a target of other Hox 3 
proteins, in addition to Hoxa2. The use of common target genes to control diverse 4 
developmental processes has been documented only for Six2 (13, 14, 31), but it 5 
could represent a more widespread aspect of Hox function in vertebrates. 6 
 7 
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Figure legends 6 
Fig. 1. Meox1 expression in the branchial arches.  7 
Whole-mount and section ISH on wild-type (A, B, C, D, F, G, H, I) and Hoxa2 mutant 8 
(E) embryos, using Meox1 (A, B, C, D, E, H), Hoxa2 (F, G), and Crabp1 (I) probes. 9 
Meox1 expression is first detected at E9.0 in the IIBA (A). At E9.5 Meox1-positive 10 
cells occupy most of the proximal area of the IIBA (B), they are still detected at E10.0 11 
(C) and no longer visible after E10.5 (not shown). Meox1 is expressed at E9.5 in both 12 
II and IIIBA (D). Meox1 expression is specifically lost in the IIBA of Hoxa2 mutant (E, 13 
arrowhead). F, Hoxa2-positive cells are detected in the entire IIBA and in 14 
rhombomere 4 (asterisk). The dotted line delimitates the proximal, Meox1-positive 15 
area of the IIBA. G, H, I. Adjacent parasagittal sections of E9.5 embryo. Hoxa2 (G) 16 
and Crabp1 (I) expressions demarcate cranial neural crest cells. Meox1 (H) is 17 
transcribed in a subpopulation of the cranial neural crest, anterior to the second arch 18 
artery (asterisk). In A, B, C, D, E, arrowheads and arrows point at IIBA and IIIBA, 19 
respectively; I= first branchial arch.  20 
Fig. 2. Hoxa2 binds the Meox1 proximal promoter. A, Clustal alignment of Meox1 21 
proximal promoter sequences from different vertebrate species. Numbers indicate 22 
nucleotides position relatively to +1 (transcriptional start site) in mouse. Light red 23 
highlights Hoxa2 binding sites. The chromatin sequence amplified in ChIP is 24 
enclosed in a red rectangle. B, The conserved Meox1 proximal promoter (red 25 
rectangle in A) is enriched in ChIP assays performed on E10.0 IIBAs in the presence 26 
of Hoxa2 antibody (a-a2= Hoxa2 antibody; IgG= non-specific antibody; EB= elution 27 
buffer. The input was diluted 1:300 prior to amplification). Specific enrichment is also 28 
 20 
detected for Hoxa2 direct target Six2, while no enrichment is observed for Intein, a 1 
control, unrelated promoter. ChIP was performed on three independent pools of 2 
samples. PCRs were performed in duplicate on each pool. Results shown are from a 3 
representative set. C, ISH on E10.5 embryo shows strong Hoxa2 expression in the 4 
IIBA (surrounded by red dots). D, Labeled Meox1 proximal promoter (red rectangle in 5 
A), incubated in the presence of Hoxa2-programmed reticulocytes, gives rise to a 6 
retarded complex (arrowhead), supershifted by the addition of anti-Hoxa2 antibody 7 
(arrow). Nucleotide substitutions in single Hoxa2 binding sites (mBS1 or mBS2, 8 
changes are shown in A) do not abolish complex formation, while no complex 9 
formation is observed when the probe contains nucleotide substitutions in both 10 
binding sites (mBS1+ 2). E, The formation of the complexes (arrowhead) is 11 
competed by the addition of cold double-stranded oligonucleotides containing Hoxa2 12 
binding sites (wtBS1, wtBS2), but not of oligonucleotides with the mutated site 13 
(mBS1, mBS2). Cold oligonucleotides were added at 200 (3,4,8,9) and 400 folds 14 
(5,6,10,11) molar excess.  15 
Fig. 3.  Hoxa2 activates the Meox1 promoter. A, Craniofacial area of E10.5 mouse 16 
embryo showing first (I) and second (II) arch (red and blue, respectively). B, Semi-17 
quantitative RT-PCR on RNA extracted from duplicates of IBA- and IIBA-derived 18 
mesenchymal cells cultured for three days (red and blue cells on top, respectively). 19 
The expression of IBA-specific genes (Six2, Ptx1, Lhx6) is maintained in IBA-derived 20 
cultures. IIBA-derived cultures do not express these genes. Hoxa2 expression is still 21 
detected in IIBA-, and is absent from IBA-derived cell cultures. C, 22 
The number of ß-galactosidase-stained IBA cells is significantly increased when 23 
4.6kb-Meox1-lacZ is co-transfected with Hoxa2 (a P < 0.001 was measured in three 24 
independent experiments). Hoxa2 fails to activate LacZ expression driven by the 25 
same promoter containing point mutation in BS1 and BS2 (4.6-mutMeox1; mutations 26 
as shown in Fig. 2A). Empty bars show the basal activity of lacZ constructs; black 27 
 21 
bars show lacZ constructs activity in the presence of Hoxa2. The results shown are 1 
the average of three independent experiments, each performed in duplicate. 2 
Fig. 4. Middle ear skeletal phenotype of Meox1-/-; Meox2-/- mouse mutants. 3 
Skeletal phenotype of wild-type (A, D), Meox1-/-; Meox2-/- (B, E) and Hoxa2-/- (C, F) 4 
E18.5 fetuses. A-C, Dissected otic capsules. In the absence of Hoxa2 stapes (s), 5 
styloid process (st) (highlighted in green in A) are replaced by mirror image copies of 6 
IBA skeletal elements (highlighted in green in C); wild-type IBA cartilages, incus (i) 7 
and malleus (m) are highlighted in orange in A, B, C. In Meox1-/-; Meox2-/- mutants, 8 
the styloid process is truncated and is formed much closer to IBA skeletal derivatives 9 
with respect to the wild-type (compare double arrow in A and B; dissection of six otic 10 
capsules revealed an identical phenotype). D-F, Ventral view of the posterior cranial 11 
base, showing an hypomorphic basioccipital bone (bo) in Meox1-/-; Meox2-/- and 12 
Hoxa2-/- mutants compared to wild-type.  13 
Fig 5. Meox2 expression in the branchial arches.  14 
Whole mount LacZ staining of E10.75 Meox2+/tm1(lacZ)Mnko embryos reveals lacZ-15 
positive cells in the posterior region of the IIBA (arrow). 16 
Fig 6. Meox1 and Hoxa2 display very similar binding activities in vitro. A, Labeled 17 
mouse Six2 promoter (nucleotide -181 to -48), incubated in the presence of Meox1- 18 
or Hoxa2- programmed reticulocytes, gives rise to a retarded complex (arrowhead 19 
and arrow, respectively). Both complexes are similarly competed by the addition of 20 
cold double-stranded oligonucleotides containing the Hoxa2 binding sites identified 21 
on Six2 promoter (wtS1, wtS2), but not by oligonucleotides containing mutated 22 
Hoxa2 binding sites (mS1, mS2). Cold oligonucleotides (sequences are shown) were 23 
added at 200 and 400 fold molar excess. B, Labeled Meox1 promoter (nucleotide -24 
235 to -102), incubated in the presence of Meox1-HA- or Hoxa2- programmed 25 
reticulocytes, gives rise to retarded complexes (arrows), supershifted by the addition 26 
of specific antibodies (arrowheads). 27 
 22 
Fig 7. Members of the Hoxa2 GRN display similar binding preferences. The 1 
sequence logo indicates the DNA recognition sequence determined by the prediction 2 
tool at http://ural.wustl.edu/flyhd. The same recognition sequences were 3 
independently identified by high-throughput binding site selection (4).  4 
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